Literature DB >> 19929703

Treatment of viral hepatitis in pregnancy.

Simona Fiore1, Valeria Savasi.   

Abstract

Viral hepatitis can be caused by the hepatitis A, B, C, D and E viruses. In the Western world, hepatitis A, B or C do not seem to influence the course of pregnancy, whereas hepatitis E infection, when contracted during the second or third trimester, seems to have a higher risk of developing into a fulminant hepatitis. Mother-to-infant transmission of hepatitis A seems to be very uncommon. The majority of HBsAg-positive and HBeAg-positive mothers can transmit the disease vertically. The timing of transmission is predominantly peripartum, and newborns of HBsAg-positive mothers should receive hepatitis B immunoglobulins within 12 h of birth, with HBV vaccine at birth and 1 and 6 months later. Hepatitis C is more often a chronic disease. Vertical transmission of hepatitis C is considered to be relatively rare but high viraemia or coinfection with HIV can increase this risk. There is currently no treatment to prevent this vertical transmission and pregnancies among HCV-positive mothers should not be discouraged. Infants should be tested for anti-HCV at 1 year and followed for the development of hepatitis. Breast feeding does not seem to play an important role in the transmission of hepatitis B and C.

Entities:  

Mesh:

Year:  2009        PMID: 19929703     DOI: 10.1517/14656560903304071

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  7 in total

1.  Hepatitis E infection during pregnancy.

Authors:  Shahnaz A Chaudhry; Natasha Verma; Gideon Koren
Journal:  Can Fam Physician       Date:  2015-07       Impact factor: 3.275

2.  Hepatitis A infection during pregnancy.

Authors:  Shahnaz A Chaudhry; Gideon Koren
Journal:  Can Fam Physician       Date:  2015-11       Impact factor: 3.275

Review 3.  Viral hepatitis vaccination during pregnancy.

Authors:  Yueyuan Zhao; Hui Jin; Xuefeng Zhang; Bei Wang; Pei Liu
Journal:  Hum Vaccin Immunother       Date:  2016-04-02       Impact factor: 3.452

4.  Burden of hepatitis E virus infection in pregnancy and maternofoetal outcomes: a systematic review and meta-analysis.

Authors:  Jean Joel Bigna; Abdou Fatawou Modiyinji; Jobert Richie Nansseu; Marie A Amougou; Moise Nola; Sébastien Kenmoe; Elvis Temfack; Richard Njouom
Journal:  BMC Pregnancy Childbirth       Date:  2020-07-28       Impact factor: 3.007

Review 5.  Viral hepatitis in pregnancy.

Authors:  Mohamed Tarek M Shata; Helal F Hetta; Yeshika Sharma; Kenneth E Sherman
Journal:  J Viral Hepat       Date:  2022-07-07       Impact factor: 3.517

6.  Seroprevalence of hepatitis E virus infection in pregnant women: a systematic review and meta-analysis.

Authors:  Tauseef Ahmad; Jin Hui; Taha Hussain Musa; Masoud Behzadifar; Mukhtiar Baig
Journal:  Ann Saudi Med       Date:  2020-04-02       Impact factor: 1.526

Review 7.  Hepatitis E Virus Immunopathogenesis.

Authors:  Kush Kumar Yadav; Scott P Kenney
Journal:  Pathogens       Date:  2021-09-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.